COVID-19 vaccine
Protest against Merkel in US Free the vaccine: Protests greet German chancellor Angela Merkel on US visit

Demonstrations calling for Germany to stop blocking patent waiver for COVID-19 vaccines were held in the US capital, Washington DC, among other places, as German chancellor Angela Merkel made an official visit to the US to meet president Joe Biden

Venezuela immunizes its population against COVID-19 with Cuban vaccine

Last week, Venezuela signed an agreement with Cuba for the purchase of 12 million doses of Abdala, just three days after the country announced and celebrated the success of its locally developed anti-COVID-19 vaccine

The G7 reality check 

In early June, the leaders of the world’s seven richest countries met in the UK to discuss global health, climate, and tax issues. Although the world is still in the midst of a pandemic, their actions leave little hope — or room — for changes for the better

How to know if a virus variant can escape vaccine protection

Amid new variants of the SARS-CoV-2 emerging across the world, experts explain how to ascertain whether a virus strain can escape the protection provided by a vaccine

Slow vaccination process dangerous, allows for rise of stronger variants

What is the new Delta variant? Is it more dangerous than earlier forms of the virus? Will old vaccines prove effective. Immunologist Dr. Satyajit Rath discusses these issues

COVID-19: Top scientists explain how India can tackle a possible third wave

India has to scale up testing, isolating and sequencing along with vaccination and decentralized critical care to face large-scale future outbreaks, say experts

Could Novavax’s COVID vaccine address some challenges in the current vaccination process?

Newsclick’s Prabir Purkayastha and immunologist Dr. Satyajit Rath discuss Covavax, the protein subunit-based vaccine manufactured by the US manufacturer Novavax

G-7 offers crumbs from its table to ‘developing’ countries

As of now, the total unvaccinated population in the world numbers 6.8 billion. The one billion doses promised by the G-7 countries can meet the needs of only 7.4% of this number

Neutralising antibodies can be marker of COVID-19 vaccine efficacy

A new research shows that even a small quantity of the neutralising antibodies indicates a strong efficacy of the vaccine

Stop blaming people for failure to vaccinate

Journalist Aunindyo Chakravarty busts the myths regarding vaccine hesitancy in India and talks about how it is in fact poor planning that has led to the crisis in this process

Indian govt. should properly explain vaccine doses gap: Satyajit Rath

Immunologist Dr. Satyajit Rath and Newsclick’s Prabir Purkayastha talk about the Indian government’s decision to extend the interval between doses

COVID-19 vaccine: Who holds intellectual property rights?

Immunologist Dr. Satyajit Rath and Newsclick’s Prabir Purkayastha talk about the recent debates on the intellectual property rights on vaccines and the possibilities of mass immunization

    × To Subscribe